Lumos Pharma Announces Abstract Accepted for Oral Presentation at the 13th Biennial Scientific Meeting of the Asia Pacific Pediatric Endocrine Society, APPES 2024
September 25, 2024 16:05 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that an...
ALTRUST Services Boosts Profitability for Medical Practices
September 25, 2024 09:00 ET
|
ALTRUST Services
Clearwater, FL, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Medical practices are increasingly pressured to optimize operations, ensure HIPAA compliance, and improve financial performance. ALTRUST Services...
Proxy Deadline Thursday September 26, 2024
September 25, 2024 07:30 ET
|
Titan Medical Inc.
TORONTO, Ontario, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) released a reminder for shareholders to vote ahead of Titan’s annual and special shareholders...
Appointment of Dr. Kalpesh Barot, MD Completes Phase One of ADIA Nutrition’s Medical Division
September 24, 2024 10:00 ET
|
ADIA Nutrition
WINTER PARK, Fla., Sept. 24, 2024 (GLOBE NEWSWIRE) -- ADIA Nutrition (OTC Pink: ADIA) is excited to announce the completion of its Board of Medical Directors with the appointment of Dr. Kalpesh...
Medical devices, SMEs in healthcare: 4,000 companies at risk of default due to new tax – reports LaPresse
September 23, 2024 11:05 ET
|
LaPresse
ROME, Sept. 23, 2024 (GLOBE NEWSWIRE) -- “In Italy, a regulation imposing a large tax threatens 4,000 companies that supply hospitals and healthcare facilities with essential medical devices,...
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366
September 23, 2024 08:00 ET
|
Assembly Biosciences, Inc.
– ABI-5366 was well-tolerated, with a favorable safety profile observed with exposure of up to 70 days – – Half-life of approximately 20 days supports once-weekly or once-monthly oral dosing; both...
Proxy Advisor Glass, Lewis & Co., Recommends Titan Shareholders Vote FOR the Amalgamation Between Titan and Conavi
September 19, 2024 11:25 ET
|
Titan Medical Inc.
TORONTO, Ontario, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to announce that a second independent proxy advisor, Glass Lewis has recommended...
Nationwide Voting Launches for ImageFIRST’s 4th Annual HeroesFIRST Contest
September 18, 2024 12:30 ET
|
ImageFIRST Healthcare Laundry Specialists
King of Prussia, PA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- ImageFIRST® proudly announces the launch of nationwide voting for its 4th Annual HeroesFIRST Contest, celebrating exceptional healthcare...
Corza Medical Named to the 2024 MedTech Big 100 List
September 18, 2024 08:55 ET
|
Corza Medical Inc.
Corza Medical, a leading global medical technology company committed to remarkable service, trusted performance, and outstanding value named to BIG100!
Independent Proxy Advisor, Institutional Shareholder Services (“ISS”), Recommends Titan Shareholders Vote FOR the Amalgamation Between Titan and Conavi
September 16, 2024 17:00 ET
|
Titan Medical Inc.
TORONTO, Ontario, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to announce that Institutional Shareholder Services (“ISS”), has released a report...